What’s Next for COPD? Understanding the Role of Biologics

For some people living with COPD, significant symptoms and exacerbations can continue despite optimised management. Emerging biologic therapies may provide another treatment option for appropriately selected patients.

Join our expert panel to explore the evolving role of biologics in COPD and learn how to identify patients who may benefit from specialist assessment.

Speakers 

• A/Prof Chee Khoo, General Practitioner
• Dr Sanjay Ramakrishnan, Respiratory Physician

The session will cover:

• Current evidence for biologic therapies in COPD
• Patient eligibility and selection
• Identifying appropriate patients in practice
• When and how to refer for specialist assessment.

Learning outcomes:

• Describe the key components of optimised COPD management, including pharmacological and non-pharmacological management, inhaler technique and management of comorbidities. 
• Outline the role of biologic therapies in COPD, including their rationale, mechanisms of action and the evidence supporting their use. 
• Identify patients who may be eligible for biologic therapy and describe appropriate referral pathways and considerations for specialist assessment.